| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.71▼ | 6.66▼ | 6.66▼ | 6.83▼ | 7.56▼ |
| MA10 | 6.72▼ | 6.78▼ | 6.78▼ | 6.93▼ | 7.26▼ |
| MA20 | 6.84▼ | 6.73▼ | 6.66▼ | 7.64▼ | 7.19▼ |
| MA50 | 7.02▼ | 7.60▼ | 7.72▼ | 7.22▼ | 5.40▲ |
| MA100 | 7.91▼ | 7.47▼ | 7.20▼ | 7.18▼ | 3.69▲ |
| MA200 | 7.13▼ | 7.48▼ | 7.50▼ | 5.88▲ | 4.83▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.040▲ | 0.038▲ | -0.159▼ | -0.126▼ |
| RSI | 45.306▼ | 43.908▼ | 43.362▼ | 41.277▼ | 49.623▼ |
| STOCH | 29.085 | 13.538▼ | 13.538▼ | 48.869 | 63.382 |
| WILL %R | -90.756▼ | -90.756▼ | -90.756▼ | -55.617 | -57.417 |
| CCI | -74.322 | -83.641 | -83.641 | -79.285 | -11.801 |
|
Wednesday, July 02, 2025 02:30 PM
ZENITH was the first of its kind in PAH to focus purely on hard outcomes like death, transplant, or long-term hospitalization. The kicker? WINREVAIR cut those risks by 76% compared to placebo, so ...
|
|
Wednesday, July 02, 2025 10:38 AM
Merck (NYSE:MRK) recently announced the FDA's priority review for an sBLA for WINREVAIR™ and results from its ZENITH trial, showcasing significant improvements in pulmonary arterial hypertension ...
|
|
Wednesday, July 02, 2025 04:43 AM
Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted priority review for its request seeking a label update for Winrevair, a treatment already approved in the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/07/25 | 6.65 | 6.65 | 6.65 | 6.65 | 15,057 |
| 02/07/25 | 6.51 | 7.00 | 6.51 | 7.00 | 31,694 |
| 01/07/25 | 6.90 | 6.92 | 6.53 | 6.61 | 13,643 |
| 30/06/25 | 6.87 | 7.195 | 6.87 | 6.90 | 16,251 |
| 27/06/25 | 6.95 | 7.19 | 6.65 | 7.00 | 4,486 |
| 26/06/25 | 7.0744 | 7.0744 | 6.6531 | 6.95 | 7,904 |
| 25/06/25 | 7.02 | 7.988 | 6.36 | 6.84 | 321,788 |
| 24/06/25 | 6.88 | 7.19 | 6.60 | 7.05 | 14,424 |
| 23/06/25 | 7.36 | 9.15 | 4.655 | 6.91 | 483,499 |
| 20/06/25 | 7.88 | 8.7086 | 7.33 | 7.43 | 108,942 |
|
|
||||
|
|
||||
|
|